Avivagen Inc
Science is in our nature
Science is in our nature
Avivagen Inc. is a publicly-listed life sciences company trading on the TSX Venture Exchange under the ticker symbol “VIV” and OTC Pink under the ticker symbol “CHEXF.” Founded in 2005, the company's slogan "Science is in our nature" reflects its commitment to developing and delivering scientifically-proven solutions for companion and production animals. With a focus on Agriculture and Manufacturing industries, Avivagen aims to utilize natural mechanisms to enhance the health of Livestock Productivity and Pet Wellness. The company recently received a Post-IPO Equity investment on 14 October 2022, giving an indication of investor confidence in its potential. With its innovative approach and promising market targets, Avivagen Inc. presents an interesting opportunity for investors seeking exposure to the life sciences sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | Unknown | - | 14 Oct 2022 | |
| Post-IPO Debt | Unknown | - | 28 Mar 2022 | |
| Post-IPO Equity | Unknown | - | 16 Feb 2021 | |
| Post-IPO Equity | Unknown | - | 27 Jan 2020 | |
| Post-IPO Equity | Unknown | - | 28 Mar 2019 |
No recent news or press coverage available for Avivagen Inc.
We care about your data, and we'd love to use cookies make your experience better.
